Redmile Group completed a $100m investment in Saluda Medical.

Synopsis

Redmile Group, a venture capital firm, completed a $100m investment in Saluda Medical, a commercial-stage medical device company, with participation from Wellington Management, TPG Life Sciences Innovation, Fidelity Management & Research Company, Action Potential Venture Capital, T. Rowe Price Associates, and Piper Heartland Healthcare Capital.

Principals

target

Saluda Medical

bidder

Redmile Group

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

sam bentzinger

Associate Vice President at Gilmartin Group

PR Consultant

target

Deal

£ 81 M

Total Value

brian johnston

Vice President at Gilmartin Group

PR Consultant

target

Deals

£ 756 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy